VentriPoint Diagnostics Ltd.
VPTDF
$0.123
$0.021821.54%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 277.74% | 37.86% | -5.93% | -30.25% | -15.06% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 277.74% | 37.86% | -5.93% | -30.25% | -15.06% |
Cost of Revenue | -100.00% | 4.17% | -27.54% | -36.71% | 8.14% |
Gross Profit | 481.98% | 42.26% | -1.05% | -29.41% | -24.56% |
SG&A Expenses | 14.32% | -4.99% | -10.58% | -4.55% | -18.54% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.06% | -2.10% | -12.09% | -3.65% | -8.78% |
Operating Income | -3.03% | 2.51% | 12.15% | 3.29% | 8.73% |
Income Before Tax | -6.61% | 0.29% | 11.38% | 3.70% | 7.64% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -6.61% | 0.29% | 11.38% | 3.70% | 7.64% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -6.61% | 0.29% | 11.38% | 3.70% | 7.64% |
EBIT | -3.03% | 2.51% | 12.15% | 3.29% | 8.73% |
EBITDA | -3.12% | 2.42% | 12.07% | 3.21% | 8.67% |
EPS Basic | -6.25% | 0.42% | 11.51% | 4.17% | 8.57% |
Normalized Basic EPS | -5.71% | 0.68% | 12.03% | 4.00% | 9.09% |
EPS Diluted | -6.25% | 0.42% | 11.51% | 4.17% | 8.57% |
Normalized Diluted EPS | -5.71% | 0.68% | 12.03% | 4.00% | 9.09% |
Average Basic Shares Outstanding | 0.23% | 0.25% | 0.38% | 0.53% | 1.36% |
Average Diluted Shares Outstanding | 0.23% | 0.25% | 0.38% | 0.53% | 1.36% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |